DE60201573D1 - Biokompatibles verbundmaterial - Google Patents

Biokompatibles verbundmaterial

Info

Publication number
DE60201573D1
DE60201573D1 DE2002601573 DE60201573T DE60201573D1 DE 60201573 D1 DE60201573 D1 DE 60201573D1 DE 2002601573 DE2002601573 DE 2002601573 DE 60201573 T DE60201573 T DE 60201573T DE 60201573 D1 DE60201573 D1 DE 60201573D1
Authority
DE
Germany
Prior art keywords
polymer
active ingredient
composite material
biocompatible composite
composite
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE2002601573
Other languages
English (en)
Other versions
DE60201573T2 (de
Inventor
Anne Kelso
Roshan Maini
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vascutek Ltd
Original Assignee
Vascutek Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vascutek Ltd filed Critical Vascutek Ltd
Application granted granted Critical
Publication of DE60201573D1 publication Critical patent/DE60201573D1/de
Publication of DE60201573T2 publication Critical patent/DE60201573T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/04—Nitro compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/42—Anti-thrombotic agents, anticoagulants, anti-platelet agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Threshing Machine Elements (AREA)
  • Refuse Collection And Transfer (AREA)
DE60201573T 2001-07-11 2002-07-08 Biokompatibles verbundmaterial Expired - Lifetime DE60201573T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0116920 2001-07-11
GBGB0116920.0A GB0116920D0 (en) 2001-07-11 2001-07-11 Delivery system
PCT/GB2002/003108 WO2003005990A1 (en) 2001-07-11 2002-07-08 Biocompatible composite

Publications (2)

Publication Number Publication Date
DE60201573D1 true DE60201573D1 (de) 2004-11-18
DE60201573T2 DE60201573T2 (de) 2006-02-16

Family

ID=9918301

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60201573T Expired - Lifetime DE60201573T2 (de) 2001-07-11 2002-07-08 Biokompatibles verbundmaterial

Country Status (8)

Country Link
US (1) US20040115237A1 (de)
EP (1) EP1349539B1 (de)
JP (1) JP2004533904A (de)
AT (1) ATE279177T1 (de)
CA (1) CA2444089A1 (de)
DE (1) DE60201573T2 (de)
GB (1) GB0116920D0 (de)
WO (1) WO2003005990A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8551512B2 (en) * 2004-03-22 2013-10-08 Advanced Cardiovascular Systems, Inc. Polyethylene glycol/poly(butylene terephthalate) copolymer coated devices including EVEROLIMUS
US7704545B2 (en) 2004-05-12 2010-04-27 Medtronic Vascular, Inc. Drug-polymer coated stent
US20210003546A1 (en) * 2018-03-09 2021-01-07 Mandom Corporation Method for detecting indicator of immune-related disease
DE102018116093A1 (de) * 2018-07-03 2020-01-09 Mühlbauer Technology Gmbh Vorrichtung zur Homogenisierung von Harzformulierungen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0537006A3 (en) * 1991-10-10 1993-06-16 Elastochem, Inc. Fluxed composites
GB2273874A (en) * 1992-12-31 1994-07-06 Pertti Olavi Toermaelae Preparation of pharmaceuticals in a polymer matrix
EP0680753A3 (de) * 1994-05-06 1996-08-28 Feinchemie Gmbh Sebnitz Metalloxidkomposit mit steuerbarer Wirkstoffabgabe.
US5869079A (en) * 1995-06-02 1999-02-09 Oculex Pharmaceuticals, Inc. Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
KR0180334B1 (ko) * 1995-09-21 1999-03-20 김윤 블럭 공중합체 미셀을 이용한 약물전달체 및 이에 약물을 봉입하는 방법
KR100355563B1 (ko) * 2000-06-23 2002-10-11 주식회사 바이오메드랩 비등성 혼합물을 이용한 조직공학용 생분해성의 다공성고분자 지지체 및 그의 제조방법

Also Published As

Publication number Publication date
WO2003005990A1 (en) 2003-01-23
EP1349539A1 (de) 2003-10-08
EP1349539B1 (de) 2004-10-13
US20040115237A1 (en) 2004-06-17
JP2004533904A (ja) 2004-11-11
CA2444089A1 (en) 2003-01-23
DE60201573T2 (de) 2006-02-16
ATE279177T1 (de) 2004-10-15
GB0116920D0 (en) 2001-09-05

Similar Documents

Publication Publication Date Title
TW200612877A (en) Bioabsorbable porous object
AU2002366083A1 (en) Matrix for the production of tissue engineered ligaments, tendons and other tissue
AU775126C (en) Substituted oxazolidinones and their use in the field of blood coagulation
ATE205391T1 (de) Nimesulid zur aüsserlichen anwendung
FI956014A (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
WO2004030572A3 (en) Retention apparatus for an external portion of a semi-implantable hearing aid
CO4290346A1 (es) Formas de dosificacion de liberacion controlada de azitromicina
WO2005065079A3 (en) Medical implants and fibrosis-inducing agents
EP2371352A3 (de) Vorrichtungen mit Proteinmatrixmaterialien sowie Verfahren zu ihrer Herstellung und Verwendung
NO934592D0 (no) Materiale for vevsbehandling omfattende fibrin eller fibrinogen, og bionedbrytbartog bioforenligg polymer
MXPA05008406A (es) Compuestos de amida tri(ciclo)-sustituida.
IL144294A0 (en) P53 inhibitors and therapeutic use of the same
ATE259658T1 (de) Anästhetische zubereitung enthaltend einen nmda- antagonisten und einen alpha-2 adrenergen agonisten
MXPA02011757A (es) Uso de suministros de fibra fraccionada en la fabricacion de productos de tisu y productos producidos por este.
GB2378920A (en) Targeted elastic laminate
WO2005065642A3 (en) Drug delivery device
DE69932510D1 (de) Vaskularisierungsinhibitoren
DE60201573D1 (de) Biokompatibles verbundmaterial
DK0981347T3 (da) Anvendelsen af levobupivacain i ansigtkirurgi
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
AU2003302375A1 (en) Artificial joint, medical implant, and methods of producing the artificial joint and medical implant
TR200002939T2 (tr) Paroksetin maleat
ES2148779T3 (es) Procedimiento para la fabricacion de una horma.
NZ528064A (en) Utilization of buprenorphine in urinary incontinence therapy
EE200200440A (et) Estramustiinfosfaadi või selle metaboliidi kasutamine taksaani toimimisvõimet suurendava ravimi valmistamiseks, toimeaine ning seda sisaldav kombineeritud preparaat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition